Arca Biopharma | ABIO - Ebitda





Ebitda Changement Date
Alterity Therapeutics Limited AUD -7.72M 2.99M 2023-06
Amgen USD 5.8B 1.25B 2026-09
Arca Biopharma USD -25.07M 5.23M 2025-03
Biogen USD 450.8M 198.9M 2026-06
Brainstorm Cell Therapeutics USD -3.04M 99K 2025-03
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Cipla INR 13.88B 154.2M 2026-09
Clal Biotechnology ILS -5.3M 2.09M 2022-12
Compugen USD -8.84M 180K 2026-06
CSL USD 3.13B 1.17B 2025-12
Cytokinetics USD -160.3M 9.02M 2026-06
Daiichi Sankyo JPY 116.06B 14.46B 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
Grifols EUR 482.04M 7.04M 2025-09
Laboratory Of America USD 674.3M 93.4M 2026-09
Myriad Genetics USD 14.3M 4M 2025-12
Otsuka Holdings JPY 174.82B 14.19B 2026-09
Pfizer USD 6.36B 350M 2026-09
United Therapeutics USD 334.2M 20.8M 2026-09